2 Stocks to Avoid Like the Plague in 2022

The stock market hasn't been in the best shape this year. Growth stocks have been hit particularly hard due to valuation concerns and impending interest rate hikes in the U.S. All these issues are merely temporary, though, and it'd be best for investors to look past them and hold on to shares of great companies.

However, some stocks are facing deeper problems and aren't worth investing in for the long haul. Let's consider two such stocks: Inovio Pharmaceuticals (NASDAQ: INO) and Cronos Group (NASDAQ: CRON).

Source Fool.com